These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 17993806

  • 1. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M, Lavallée PC, Labreuche J, Amarenco P.
    Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
    [Abstract] [Full Text] [Related]

  • 2. Statins and stroke prevention.
    Paciaroni M, Bogousslavsky J.
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
    [Abstract] [Full Text] [Related]

  • 3. [Statins in stroke prevention].
    Gedikli O, Baykan M.
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):217-22. PubMed ID: 18524729
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin in prevention of stroke and transient ischaemic attack.
    Amarenco P.
    Expert Opin Pharmacother; 2007 Nov; 8(16):2789-97. PubMed ID: 17956199
    [Abstract] [Full Text] [Related]

  • 5. Drug insight: translating evidence on statin therapy into clinical benefits.
    Sanossian N, Ovbiagele B.
    Nat Clin Pract Neurol; 2008 Jan; 4(1):43-9. PubMed ID: 18199996
    [Abstract] [Full Text] [Related]

  • 6. Statins and stroke prevention.
    Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J.
    Cerebrovasc Dis; 2007 Jan; 24(2-3):170-82. PubMed ID: 17596685
    [Abstract] [Full Text] [Related]

  • 7. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
    Chaturvedi S, Zivin J, Breazna A, Amarenco P, Callahan A, Goldstein LB, Hennerici M, Sillesen H, Rudolph A, Welch MA, SPARCL Investigators.
    Neurology; 2009 Feb 24; 72(8):688-94. PubMed ID: 18768917
    [Abstract] [Full Text] [Related]

  • 8. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF.
    Ned Tijdschr Geneeskd; 2006 Sep 30; 150(39):2127-30. PubMed ID: 17059084
    [Abstract] [Full Text] [Related]

  • 9. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR.
    Am J Cardiovasc Drugs; 2010 Sep 30; 10 Suppl 1():10-7. PubMed ID: 21391729
    [Abstract] [Full Text] [Related]

  • 10. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
    Schwertz DW, Badellino KO.
    J Cardiovasc Nurs; 2008 Sep 30; 23(1):8-13. PubMed ID: 18158500
    [Abstract] [Full Text] [Related]

  • 11. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD, Cannon CP.
    Curr Opin Lipidol; 2006 Dec 30; 17(6):626-30. PubMed ID: 17095906
    [Abstract] [Full Text] [Related]

  • 12. [Statins and stroke].
    Chudzik W, Kaczorowska B, Chmielewski H, Przybyła M, Gałka M.
    Pol Merkur Lekarski; 2005 Oct 30; 19(112):591-5. PubMed ID: 16379334
    [Abstract] [Full Text] [Related]

  • 13. Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?
    Lingsma HF, Steyerberg EW, Scholte op Reimer WJ, van Domburg R, Dippel DW, Netherlands Stroke Survey Investigators.
    Acta Neurol Scand; 2010 Jul 30; 122(1):15-20. PubMed ID: 20047571
    [Abstract] [Full Text] [Related]

  • 14. On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study.
    van den Bogaard B, van den Born BJ, Fayyad R, Waters DD, DeMicco DA, LaRosa JC, Kastelein JJ, Holme I, Treating to New Targets investigators.
    Eur J Clin Invest; 2011 Feb 30; 41(2):134-42. PubMed ID: 20868450
    [Abstract] [Full Text] [Related]

  • 15. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
    Moonis M, Fisher M.
    Expert Rev Neurother; 2004 Mar 30; 4(2):241-7. PubMed ID: 15853565
    [Abstract] [Full Text] [Related]

  • 16. Statins for stroke prevention: disappointment and hope.
    Amarenco P, Tonkin AM.
    Circulation; 2004 Jun 15; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS, Poulter NR, Dahlof B, Wedel H, ASCOT Investigators.
    J Hypertens; 2009 May 15; 27(5):947-54. PubMed ID: 19318984
    [Abstract] [Full Text] [Related]

  • 18. Stroke prevention, blood cholesterol and statins.
    Amarenco P, Lavallée PC, Labreuche J, Touboul PJ.
    Acta Neurol Taiwan; 2005 Sep 15; 14(3):96-112. PubMed ID: 16252611
    [Abstract] [Full Text] [Related]

  • 19. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B, Martínez-Sánchez P, Díez-Tejedor E.
    Cerebrovasc Dis; 2009 Sep 15; 27 Suppl 1():126-33. PubMed ID: 19342842
    [Abstract] [Full Text] [Related]

  • 20. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E, Davidson MH.
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr 15; 16(2):183-8. PubMed ID: 19262375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.